Kay DR - Search Results

1

Plasma protein binding of prednisolone in normal volunteers and arthritic patients.

Ağabeyoğlu IT, Bergstrom RF, Gillespie WR, Wagner JG, Kay DR. Ağabeyoğlu IT, et al. Among authors: kay dr. Eur J Clin Pharmacol. 1979;16(6):399-404. doi: 10.1007/BF00568200. Eur J Clin Pharmacol. 1979. PMID: 527636 Free article. No abstract available.

2

Plasma protein-binding parameters of prednisolone in immune disease patients receiving long-term prednisone therapy.

Wagner JG, Wexler D, Ağabeyoğlu IT, Bergstrom RF, Sakmar E, Kay DR. Wagner JG, et al. Among authors: kay dr. J Lab Clin Med. 1981 Apr;97(4):487-501. J Lab Clin Med. 1981. PMID: 7205057

3

Penicillamine kinetics in normal subjects.

Bergstrom RF, Kay DR, Harkcom TM, Wagner JG. Bergstrom RF, et al. Among authors: kay dr. Clin Pharmacol Ther. 1981 Sep;30(3):404-13. doi: 10.1038/clpt.1981.180. Clin Pharmacol Ther. 1981. PMID: 7273605 Free article.

4

A sensitive high-pressure liquid chromatographic method for the determination of prednisone, prednisolone and hydrocortisone in plasma.

Ağabeyoğlu IT, Wagner JG, Kay DR. Ağabeyoğlu IT, et al. Among authors: kay dr. Res Commun Chem Pathol Pharmacol. 1980 Apr;28(1):163-76. Res Commun Chem Pathol Pharmacol. 1980. PMID: 7394312

5

High-performance liquid chromatographic determination of penicillamine in whole blood, plasma, and urine.

Bergstrom RF, Kay DR, Wagner JG. Bergstrom RF, et al. Among authors: kay dr. J Chromatogr. 1981 Mar 13;222(3):445-52. doi: 10.1016/s0378-4347(00)84145-6. J Chromatogr. 1981. PMID: 7228952 Free article.

6

The in vitro loss of penicillamine in plasma, albumin solutions, and whole blood: implications for pharmacokinetic studies of penicillamine.

Bergstrom RF, Kay DR, Wagner JG. Bergstrom RF, et al. Among authors: kay dr. Life Sci. 1980 Jul 21;27(3):189-98. doi: 10.1016/0024-3205(80)90137-x. Life Sci. 1980. PMID: 6772907 Free article. No abstract available.

7

Elimination of alcohol from human blood.

Wagner JG, Wilkinson PK, Sedman AJ, Kay DR, Weidler DJ. Wagner JG, et al. Among authors: kay dr. J Pharm Sci. 1976 Jan;65(1):152-4. doi: 10.1002/jps.2600650142. J Pharm Sci. 1976. PMID: 1255425 No abstract available.

8

Pharmacokinetics of ethanol after oral administration in the fasting state.

Wilkinson PK, Sedman AJ, Sakmar E, Kay DR, Wagner JG. Wilkinson PK, et al. Among authors: kay dr. J Pharmacokinet Biopharm. 1977 Jun;5(3):207-24. doi: 10.1007/BF01065396. J Pharmacokinet Biopharm. 1977. PMID: 881642 Free article. No abstract available.

9

Dose-related effects of phenobarbitone on human sleep-waking patterns.

Karacan I, Orr W, Roth T, Kramer M, Thornby J, Bingham S, Kay D. Karacan I, et al. Br J Clin Pharmacol. 1981 Sep;12(3):303-13. doi: 10.1111/j.1365-2125.1981.tb01218.x. Br J Clin Pharmacol. 1981. PMID: 7295460 Free PMC article. Clinical Trial.

10

Dose-related effects of flurazepam on human sleep-walking patterns.

Karacan I, Orr W, Roth T, Kramer M, Thornby J, Bingham S, Kay D. Karacan I, et al. Psychopharmacology (Berl). 1981;73(4):332-9. doi: 10.1007/BF00426461. Psychopharmacology (Berl). 1981. PMID: 6789354 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page